|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. April 5–2021.(Epub ahead of
print). View Article : Google Scholar
|
|
2
|
Wang Z, Han W, Xue F, Zhao Y, Wu P, Chen
Y, Yang C, Gu W and Jiang J: Nationwide gastric cancer prevention
in China, 2021–2035: A decision analysis on effect, affordability
and cost-effectiveness optimisation. Gut. 71:2391–2400. 2022.
View Article : Google Scholar
|
|
3
|
Li Y, Feng A, Zheng S, Chen C and Lyu J:
Recent estimates and predictions of 5-year survival in patients
with gastric cancer: A model-based period analysis. Cancer Control.
29:107327482210992272022. View Article : Google Scholar
|
|
4
|
Zhou Y, Xia L, Lin J, Wang H, Oyang L, Tan
S, Tian Y, Su M, Wang H, Cao D and Liao Q: Exosomes in
nasopharyngeal carcinoma. J Cancer. 9:767–777. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loh CY, Chai JY, Tang TF, Wong WF, Sethi
G, Shanmugam MK, Chong PP and Looi CY: The E-Cadherin and
N-Cadherin Switch in Epithelial-to-Mesenchymal transition:
Signaling, therapeutic implications, and challenges. Cells.
8:11182019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maeda M, Johnson KR and Wheelock MJ:
Cadherin switching: Essential for behavioral but not morphological
changes during an epithelium-to-mesenchyme transition. J Cell Sci.
118:873–887. 2005. View Article : Google Scholar
|
|
7
|
Park M, Kim D, Ko S, Kim A, Mo K and Yoon
H: Breast cancer metastasis: Mechanisms and therapeutic
implications. Int J Mol Sci. 23:68062022. View Article : Google Scholar
|
|
8
|
Sharaireh AM, Fitzpatrick LM, Ward CM,
McKay TR and Unwin RD: Epithelial cadherin regulates transition
between the naïve and primed pluripotent states in mouse embryonic
stem cells. Stem Cells. 38:1292–1306. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Corso G, Figueiredo J, De Angelis SP,
Corso F, Girardi A, Pereira J, Seruca R, Bonanni B, Carneiro P,
Pravettoni G, et al: E-cadherin deregulation in breast cancer. J
Cell Mol Med. 24:5930–5936. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fitzgerald RC and Caldas C: E-cadherin
mutations and hereditary gastric cancer: Prevention by resection?
Dig Dis. 20:23–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Setia N, Agoston AT, Han HS, Mullen JT,
Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A,
Lennerz JK, et al: A protein and mRNA expression-based
classification of gastric cancer. Mod Pathol. 29:772–784. 2016.
View Article : Google Scholar
|
|
12
|
Zhao C, Feng Z, He H, Zang D, Du H, Huang
H, Du Y, He J, Zhou Y and Nie Y: Protein expression-based
classification of gastric cancer by immunohistochemistry of tissue
microarray. PLoS One. 15:e02388362020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Caldeira J, Figueiredo J, Brás-Pereira C,
Carneiro P, Moreira AM, Pinto MT, Relvas JB, Carneiro F, Barbosa M,
Casares F, et al: E-cadherin-defective gastric cancer cells depend
on Laminin to survive and invade. Hum Mol Genet. 24:5891–5900.
2015. View Article : Google Scholar
|
|
15
|
Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY,
Lai KH, Tseng HH, Chou NH, Huang MS, Tseng CJ and Hsiao M: Loss of
E-cadherin expression correlates with poor differentiation and
invasion into adjacent organs in gastric adenocarcinomas. Cancer
Lett. 201:97–106. 2003. View Article : Google Scholar
|
|
16
|
Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L,
Liu JY, Pu J and Lv J: Updates on global epidemiology, risk and
prognostic factors of gastric cancer. World J Gastroenterol.
29:2452–2468. 2023. View Article : Google Scholar
|
|
17
|
Shin HS, Oh SJ and Suh BJ: Factors related
to morbidity in elderly gastric cancer patients undergoing
gastrectomies. J Gastric Cancer. 14:173–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song P, Wu L, Jiang B, Liu Z, Cao K and
Guan W: Age-specific effects on the prognosis after surgery for
gastric cancer: A SEER population-based analysis. Oncotarget.
7:48614–48624. 2016. View Article : Google Scholar
|
|
19
|
Hoffman KE, Neville BA, Mamon HJ, Kachnic
LA, Katz MS, Earle CC and Punglia RS: Adjuvant therapy for elderly
patients with resected gastric adenocarcinoma: Population-based
practices and treatment effectiveness. Cancer. 118:248–257. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seo JY, Jin EH, Jo HJ, Yoon H, Shin CM,
Park YS, Kim N, Jung HC and Lee DH: Clinicopathologic and molecular
features associated with patient age in gastric cancer. World J
Gastroenterol. 21:6905–6913. 2015. View Article : Google Scholar
|
|
21
|
Suh DD, Oh ST, Yook JH and Kim BS and Kim
BS: Differences in the prognosis of early gastric cancer according
to sex and age. Therap Adv Gastroenterol. 10:219–229. 2017.
View Article : Google Scholar
|
|
22
|
Lim JH, Lee DH, Shin CM, Kim N, Park YS,
Jung HC and Song IS: Clinicopathological features and surgical
safety of gastric cancer in elderly patients. J Korean Med Sci.
29:1639–1645. 2014. View Article : Google Scholar
|
|
23
|
Lee JY, Kim HI, Kim YN, Hong JH, Alshomimi
S, An JY, Cheong JH, Hyung WJ, Noh SH and Kim CB: Clinical
significance of the prognostic nutritional index for predicting
Short- and Long-term surgical outcomes after Gastrectomy: A
retrospective analysis of 7781 gastric cancer patients. Medicine
(Baltimore). 95:e35392016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Del Rio P, Viani L, Bertocchi E, Iapichino
G, Luzietti E, Dell'Abate P and Sianesi M: The prognostic role of
tumor size in patients with gastric cancer. Ann Ital Chir.
88:478–484. 2017.PubMed/NCBI
|
|
25
|
Lee JH, Choi IJ, Han HS, Kim YW, Ryu KW,
Yoon HM, Eom BW, Kim CG, Lee JY, Cho SJ, et al: Risk of lymph node
metastasis in differentiated type mucosal early gastric cancer
mixed with minor undifferentiated type histology. Ann Surg Oncol.
22:1813–1819. 2015. View Article : Google Scholar
|
|
26
|
Tan YE, Wang PL, Yin SC, Zhang C, Hou WB
and Xu HM: Thirty-year trends in clinicopathologic characteristics
and prognosis after gastrectomy for gastric cancer: A single
institution in Northern China. J Cancer. 11:1056–1062. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kulig P, Pach R, Majewska O and Kulig J:
Clinicopathological prognostic factors determining outcomes of
treatment in gastric cancer surgery. In Vivo. 36:2927–2935. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen D, Fu M, Chi L, Lin L, Cheng J, Xue
W, Long C, Jiang W, Dong X, Sui J, et al: Prognostic and predictive
value of a pathomics signature in gastric cancer. Nat Commun.
13:69032022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Aken E, De Wever O, Correia da Rocha
AS and Mareel M: Defective E-cadherin/catenin complexes in human
cancer. Virchows Arch. 439:725–751. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cavallaro U and Christofori G: Cell
adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
St Croix B, Sheehan C, Rak JW, Flørenes
VA, Slingerland JM and Kerbel RS: E-Cadherin-dependent growth
suppression is mediated by the cyclin-dependent kinase inhibitor
p27(KIP1). J Cell Biol. 142:557–571. 1998. View Article : Google Scholar
|
|
32
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar
|
|
33
|
Cowell CF, Yan IK, Eiseler T, Leightner
AC, Döppler H and Storz P: Loss of cell-cell contacts induces
NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell
Biochem. 106:714–728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar
|
|
35
|
Becker KF, Atkinson MJ, Reich U, Becker I,
Nekarda H, Siewert JR and Höfler H: E-cadherin gene mutations
provide clues to diffuse type gastric carcinomas. Cancer Res.
54:3845–3852. 1994.PubMed/NCBI
|
|
36
|
Strathdee G: Epigenetic versus genetic
alterations in the inactivation of E-cadherin. Semin Cancer Biol.
12:373–379. 2002. View Article : Google Scholar
|
|
37
|
Caldas C, Carneiro F, Lynch HT, Yokota J,
Wiesner GL, Powell SM, Lewis FR, Huntsman DG, Pharoah PD, Jankowski
JA, et al: Familial gastric cancer: Overview and guidelines for
management. J Med Genet. 36:873–880. 1999.
|
|
38
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar
|
|
39
|
Tedaldi G, Molinari C, São José C,
Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M,
Saragoni L, Morgagni P, et al: Genetic and epigenetic alterations
of CDH1 regulatory regions in hereditary and sporadic gastric
cancer. Pharmaceuticals (Basel). 14:4572021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gjyshi O, Vashi P, Seewald L, Kohan M,
Abboud E, Fowler E, Suppiah R and Halabi H: Therapeutic and
prophylactic gastrectomy in a family with hereditary diffuse
gastric cancer secondary to a CDH1 mutation: A case series. World J
Surg Oncol. 16:1432018. View Article : Google Scholar
|
|
41
|
Fukui Y: Mechanisms behind signet ring
cell carcinoma formation. Biochem Biophys Res Commun.
450:1231–1233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hamilton LE, Jones K, Church N and
Medlicott S: Synchronous appendiceal and intramucosal gastric
signet ring cell carcinomas in an individual with CDH1-associated
hereditary diffuse gastric carcinoma: A case report of a novel
association and review of the literature. BMC Gastroenterol.
13:1142013. View Article : Google Scholar
|
|
43
|
Gamallo C, Palacios J, Suarez A, Pizarro
A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin
expression with differentiation grade and histological type in
breast carcinoma. Am J Pathol. 142:987–993. 1993.
|
|
44
|
Romero-Pérez L, López-García MÁ,
Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E,
Matias-Guiu X, Soslow RA and Palacios J: ZEB1 overexpression
associated with E-cadherin and microRNA-200 downregulation is
characteristic of undifferentiated endometrial carcinoma. Mod
Pathol. 26:1514–1524. 2013. View Article : Google Scholar
|
|
45
|
Umbas R, Isaacs WB, Bringuier PP,
Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM and Schalken
JA: Decreased E-cadherin expression is associated with poor
prognosis in patients with prostate cancer. Cancer Res.
54:3929–3933. 1994.PubMed/NCBI
|
|
46
|
Moreno-Bueno G, Cubillo E, Sarrió D,
Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra
A, Portillo F, et al: Genetic profiling of epithelial cells
expressing E-cadherin repressors reveals a distinct role for Snail,
Slug, and E47 factors in epithelial-mesenchymal transition. Cancer
Res. 66:9543–9556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vandewalle C, Comijn J, De Craene B,
Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F and
Berx G: SIP1/ZEB2 induces EMT by repressing genes of different
epithelial cell-cell junctions. Nucleic Acids Res. 33:6566–6578.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Beauchemin N and Arabzadeh A:
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs)
in cancer progression and metastasis. Cancer Metastasis Rev.
32:643–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xing X, Tang YB, Yuan G, Wang Y, Wang J,
Yang Y and Chen M: The prognostic value of E-cadherin in gastric
cancer: A meta-analysis. Int J Cancer. 132:2589–2596. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gullo I, Grillo F, Mastracci L, Vanoli A,
Carneiro F, Saragoni L, Limarzi F, Ferro J, Parente P and Fassan M:
Precancerous lesions of the stomach, gastric cancer and hereditary
gastric cancer syndromes. Pathologica. 112:166–185. 2020.
View Article : Google Scholar
|
|
53
|
Park JM, Jang YJ, Kim JH, Park SS, Park
SH, Kim SJ, Mok YJ and Kim CS: Gastric cancer histology:
Clinicopathologic characteristics and prognostic value. J Surg
Oncol. 98:520–525. 2008. View Article : Google Scholar
|
|
54
|
Marchesi F, Piemonti L, Mantovani A and
Allavena P: Molecular mechanisms of perineural invasion, a
forgotten pathway of dissemination and metastasis. Cytokine Growth
Factor Rev. 21:77–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ruibal Morell A: CEA serum levels in
non-neoplastic disease. Int J Biol Markers. 7:160–166. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang S, Li JZ, Du T, Li HQ, Hu RH, Ma CY,
Cui XM, Song C and Jiang XH: The modified Glasgow prognostic score
predicts survival in gastric cancer patients with normal CEA and
CA19-9. Can J Gastroenterol Hepatol. 2022:39530042022. View Article : Google Scholar
|
|
57
|
Nakanishi Y, Ohara M, Domen H, Shichinohe
T, Hirano S and Ishizaka M: Differences in risk factors between
patterns of recurrence in patients after curative resection for
advanced gastric carcinoma. World J Surg Oncol. 11:982013.
View Article : Google Scholar
|
